Skip to content
stoqly

Synopsys

SNPS Nasdaq Application Software Financials FY2016–FY2025

Synopsys' revenue rose 15.1% to $7.1 billion in fiscal 2025. Its operating margin was 13.0%, down from 22.1% a year earlier. Free cash flow was $1.3 billion, up 6.4%. The diluted share count rose 6.2%.

Last close · Oct 23, 2026

$430.14

1.8%
Value it Compare
Revenue Total sales reported in the income statement.
$7.1B
15.1% vs prior year
Operating margin Operating income as a share of revenue.
13.0%
9.2 pts
Net income Profit after all expenses, interest and tax.
$1.3B
41.1%
Free cash flow Cash from operations minus capital spending.
$1.3B
6.4%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
4.0%
22.5 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$82.7B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
75.2x
On $5.72 EPS (TTM)

What Synopsys does

No business description yet.

Legal name
SYNOPSYS INC
Fiscal year ends
October 31, 2025
Latest annual report
—
Accession · CIK
0000883241-25-000028
0000883241

Revenue and margins

Synopsys had $7.1B of revenue in fiscal 2025, up 15.1% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 18.6% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $1.3B in fiscal 2025, 19.1% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Synopsys returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 6.2%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Synopsys yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of −$10.5B and divides by 165.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 75.2x · peers 32.7x · sector 33.0x.

Balance sheet

Cash, debt and the ratios that show how comfortably Synopsys can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $1.6B$1.6B$1.6B$4.1B$3.0B
Debt incl. finance leases $25.1M$20.8M$18.1M$15.6M$13.5B
Net debt / EBITDA −1.7x−1.1x−1.0x−2.4x6.7x
Debt / equity 0.0x0.0x0.0x0.0x0.5x
Interest coverage 218.4x676.5x1,080.9x36.8x2.1x
Current ratio 1.2x1.1x1.2x2.4x1.6x
Quick ratio 1.1x1.0x1.0x2.3x1.5x
Total assets $8.8B$9.4B$10.3B$13.1B$48.2B
Total liabilities $3.5B$3.9B$4.1B$4.1B$19.9B
Shareholders' equity $5.3B$5.5B$6.1B$9.0B$28.3B
Net debt (− = net cash) −$1.6B−$1.5B−$1.6B−$4.0B$10.5B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$59.9M

5 insiders

Of sales under plans

89%

$53.2M

DateInsiderTradeSharesPriceValueFiling
Oct 15, 2026 Sassine GhaziPresident and CEO, Director Sold plan 14,604 $462.84 $6.8M Form 4
Oct 6, 2026 Janet LeeGC & Corporate Secretary Sold 1,144 $502.52 $0.6M Form 4
Oct 6, 2026 Sudhindra KankanwadiDeputy CFO & CAO Sold 9,170 $500.00 $4.6M Form 4
Oct 5, 2026 Sudhindra KankanwadiDeputy CFO & CAO Sold 3,000 $484.78 $1.5M Form 4
Sep 15, 2026 Sassine GhaziPresident and CEO, Director Sold plan 14,604 $374.88 $5.5M Form 4
Sep 1, 2026 Geus Aart DeExecutive Chair, Director Sold plan 24,641 $419.44 $10.3M Form 4
Aug 31, 2026 Geus Aart DeExecutive Chair, Director Sold plan 25,000 $441.76 $11.0M Form 4
Aug 28, 2026 Geus Aart DeExecutive Chair, Director Sold plan 25,000 $445.55 $11.1M Form 4
Jun 15, 2026 Sassine GhaziPresident and CEO, Director Sold plan 14,603 $458.96 $6.7M Form 4
Jun 12, 2026 Shelagh GlaserCFO Sold plan 3,394 $450.02 $1.5M Form 4
Jan 12, 2026 Janet LeeGC & Corporate Secretary Sold plan 250 $530.00 $0.1M Form 4
Jan 7, 2026 Janet LeeGC & Corporate Secretary Sold plan 250 $510.00 $0.1M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✓ ✓ ✕
Cash from operations exceeds net income ✓ ✕ ✓
Debt fell relative to assets ✓ ✓ ✕
Current ratio rose ✓ ✓ ✕
Share count didn't rise ✓ ✕ ✕
Gross margin rose ✓ ✕ ✕
Revenue rose relative to assets ✕ ✓ ✕
F-score 8 / 96 / 93 / 9
Accruals ratio −4.8%7.3%−0.6%
Altman Z'' 4.797.192.63

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Synopsys SNPS $82.7B 15.1% 13.0% 19.1% 4.0% 75.2x 3
Autodesk ADSK $53.2B 17.5% 21.9% 33.4% 37.0% 32.7x 8 Compare →
Atlassian TEAM $59.2B 26.0% 0.2% 20.1% — — 7 Compare →
Cadence Design Systems CDNS $86.6B 14.1% 28.2% 30.0% 23.7% 73.8x 5 Compare →
OpenText OTEX $7.0B 1.5% 20.6% 15.4% 9.0% 10.8x 9 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $2.4B $2.7B $3.1B $3.4B $3.7B $4.2B $5.1B $5.3B $6.1B $7.1B
Gross profit $1.9B $2.1B $2.4B $2.6B $2.9B $3.3B $3.7B $4.3B $4.9B $5.4B
Research and development $857M $909M $1.1B $1.1B $1.3B $1.5B $1.6B $1.8B $2.1B $2.5B
Operating income $317M $348M $360M $520M $620M $735M $1.1B $1.3B $1.4B $915M
Interest expense $3.8M $7.3M $15.6M $11.7M $5.1M $3.4M $1.7M $1.2M $36.8M $447M
Pretax income $330M $383M $364M $546M $638M $806M $1.1B $1.3B $1.5B $1.4B
Income tax $62.7M $247M −$69.0M $13.1M −$25.3M $49.2M $139M $90.2M $99.7M $56.0M
Net income $267M $137M $433M $532M $664M $758M $985M $1.2B $2.3B $1.3B
Diluted EPS $1.73 $0.88 $2.82 $3.45 $4.27 $4.81 $6.29 $7.92 $14.51 $8.04
Diluted shares 0.15B 0.15B 0.15B 0.15B 0.16B 0.16B 0.16B 0.16B 0.16B 0.17B
Cash flow
Cash from operations $587M $633M $424M $801M $991M $1.5B $1.7B $1.7B $1.4B $1.5B
Capital expenditure $66.9M $70.3M $99.0M $198M $155M $93.8M $137M $190M $140M $170M
Free cash flow $520M $562M $325M $602M $837M $1.4B $1.6B $1.5B $1.3B $1.3B
Depreciation and amortization $207M $189M $209M $202M $210M $204M $228M $247M $295M $660M
Stock-based compensation $97.6M $108M $140M $155M $249M $345M $459M $563M $692M $893M
Acquisitions $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Share buybacks $400M $380M $400M $329M $242M $753M $1.1B $1.2B $0.0M $0.0M
Dividends paid $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Dividends and buybacks $400M $380M $400M $329M $242M $753M $1.1B $1.2B $0.0M $0.0M
Balance sheet
Cash and short-term investments $1.1B $1.0B $723M $729M $1.2B $1.6B $1.6B $1.6B $4.1B $3.0B
Total debt $0.0M $134M $126M $120M $101M $25.1M $20.8M $18.1M $15.6M $13.5B
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Current assets $1.7B $1.7B $1.5B $1.7B $2.5B $2.8B $3.0B $3.4B $6.5B $6.0B
Current liabilities $1.7B $1.6B $2.1B $1.8B $2.1B $2.4B $2.8B $3.0B $2.7B $3.7B
Inventory $0.0M $61.9M $122M $142M $192M $229M $212M $326M $362M $365M
Property and equipment, net $257M $266M $309M $430M $484M $472M $483M $550M $563M $697M
Total assets $5.2B $5.4B $6.1B $6.4B $8.0B $8.8B $9.4B $10.3B $13.1B $48.2B
Total liabilities $2.0B $2.1B $2.7B $2.3B $3.1B $3.5B $3.9B $4.1B $4.1B $19.9B
Shareholders' equity $3.2B $3.3B $3.5B $4.1B $4.9B $5.3B $5.5B $6.1B $9.0B $28.3B
Margins
Gross margin 77.6% 76.0% 76.4% 77.6% 78.4% 79.5% 73.2% 80.6% 79.7% 77.0%
Operating margin 13.1% 12.8% 11.5% 15.5% 16.8% 17.5% 22.6% 23.9% 22.1% 13.0%
EBITDA margin 21.7% 19.7% 18.2% 21.5% 22.5% 22.3% 27.1% 28.6% 26.9% 22.3%
Net margin 11.0% 5.0% 13.9% 15.8% 18.0% 18.0% 19.4% 23.1% 36.9% 18.9%
FCF margin 21.5% 20.6% 10.4% 17.9% 22.7% 33.3% 31.5% 28.5% 20.7% 19.1%
Returns
Return on capital 12.1% 7.8% 13.7% 16.0% 17.1% 18.4% 26.0% 27.7% 26.5% 4.0%
Return on capital employed 9.1% 9.5% 9.2% 12.0% 11.8% 12.0% 17.7% 18.2% 15.3% 3.3%
Return on equity 8.4% 4.2% 12.8% 14.1% 14.8% 14.9% 18.2% 21.1% 29.9% 7.1%
Return on assets 5.2% 2.6% 7.5% 8.5% 9.2% 9.0% 10.8% 12.5% 19.3% 4.4%
Growth
Revenue growth 8.0% 12.5% 14.5% 7.7% 9.7% 14.1% 20.9% 4.7% 15.2% 15.1%
Net income growth 18.1% −48.8% 216.7% 23.1% 24.8% 14.0% 30.0% 24.9% 84.0% −41.1%
EPS growth 21.0% −49.1% 220.5% 22.3% 23.8% 12.7% 30.8% 25.9% 83.2% −44.6%
FCF growth 27.3% 8.2% −42.1% 85.1% 38.9% 67.2% 14.5% −5.5% −16.3% 6.4%
Share count change −2.1% 0.1% −1.0% 0.5% 1.0% 1.1% −0.5% −0.8% 0.5% 6.2%
Financial health
Net debt / EBITDA −2.1x −1.7x −1.1x −0.8x −1.4x −1.7x −1.1x −1.0x −2.4x 6.7x
Debt / equity 0.0x 0.0x 0.0x 0.0x 0.0x 0.0x 0.0x 0.0x 0.0x 0.5x
Interest coverage 84.2x 47.6x 23.1x 44.6x 120.7x 218.4x 676.5x 1,080.9x 36.8x 2.1x
Current ratio 1.0x 1.0x 0.7x 1.0x 1.2x 1.2x 1.1x 1.2x 2.4x 1.6x
Quick ratio 1.0x 1.0x 0.7x 0.9x 1.1x 1.1x 1.0x 1.0x 2.3x 1.5x
Capital allocation
Capex / revenue 2.8% 2.6% 3.2% 5.9% 4.2% 2.2% 2.7% 3.6% 2.3% 2.4%
Stock comp / revenue 4.0% 4.0% 4.5% 4.6% 6.8% 8.2% 9.0% 10.6% 11.3% 12.7%
Payouts / FCF 77.0% 67.6% 122.9% 54.7% 28.9% 53.8% 68.7% 76.7% 0.0% 0.0%
Quality scores
Piotroski F-score 8.0 5.0 7.0 7.0 8.0 5.0 7.0 8.0 6.0 3.0
Altman Z'' 3.3 3.4 2.5 4.0 4.1 4.2 4.4 4.8 7.2 2.6
Accruals ratio −6.2% −9.3% 0.1% −4.3% −4.5% −8.8% −8.3% −4.8% 7.3% −0.6%

Source: SEC EDGAR XBRL filings (CIK 0000883241). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open